IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.

Autor(es): Tsukaguchi M.; Tagawa Y.; Takeuchi H.; Yuki N.


Imprenta: Journal of Neurology, Neurosurgery, and Psychiatry, v. 65, n. 3, p. 407-408, 1998


Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Viral infections ; Guillain-Barre Syndrome - Immunology


Data de publicação: 1998